796355983	796355983	CD	B-NP	O
|	|	NN	I-NP	O
AMC	AMC	NN	I-NP	O
|	|	NN	I-NP	O
22883072	22883072	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8848047	8848047	CD	B-NP	O
|	|	CC	I-NP	O
9/6/2005	9/6/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2005	11/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/4/2005	10/4/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MILO	MILO	NNP	B-NP	O
SASENGBONG	SASENGBONG	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Memp	Memp	NNP	B-NP	O
Moreford	Moreford	NNP	I-NP	O
Ter	Ter	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
COPD	COPD	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
can	can	MD	B-VP	O
usually	usually	RB	I-VP	O
walk	walk	VB	I-VP	O
a	a	DT	B-NP	O
block	block	NN	I-NP	O
before	before	IN	B-PP	O
becoming	become	VBG	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
over	over	IN	B-PP	O
these	these	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
can	can	MD	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
walk	walk	VB	I-VP	O
several	several	JJ	B-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
with	with	IN	B-PP	O
whitish	whitish	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	O	O
recently	recently	RB	B-VP	O
recovered	recover	VBD	I-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
stable	stable	JJ	B-NP	O
3-pillow	3-pillow	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
for	for	IN	B-PP	O
many	many	JJ	B-NP	O
years	year	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
note	note	VB	I-VP	O
a	a	DT	B-NP	O
5-pound	5-pound	JJ	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
by	by	IN	B-PP	O
both	both	CC	O	O
cardiology	cardiology	NN	B-NP	O
and	and	CC	O	O
renal	renal	JJ	B-ADJP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
by	by	IN	B-PP	O
MRI	MRI	NN	B-NP	B-protein
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
2004	2004	CD	I-NP	O
and	and	CC	O	O
recently	recently	RB	B-VP	O
had	have	VBD	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
from	from	IN	B-PP	O
1.6	1.6	CD	B-NP	O
to	to	TO	B-PP	O
2.7	2.7	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	O	O
nonsteroidal	nonsteroidal	JJ	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
extra	extra	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

So	So	RB	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
run	run	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
mild	mild	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	B-protein
air	air	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
nebulizers	nebulizer	NNS	B-NP	O
and	and	CC	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
some	some	DT	B-NP	O
left-sided	left-sided	JJ	I-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
inspiration	inspiration	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
minutes	minute	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
associated	associate	VBN	I-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
EKG	EKG	NN	I-NP	O
showed	show	VBD	B-VP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	VBZ	B-VP	O
V2	V2	NN	B-NP	B-protein
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Allopurinol	Allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Alupent	Alupent	NN	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NN	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Clonidine	Clonidine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
180	180	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
27	27	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
62	62	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
minoxidil	minoxidil	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nicardipine	nicardipine	NN	B-NP	O
SR	SR	NN	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Pulmicort	Pulmicort	NNP	B-NP	O
1	1	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Rofecoxib	Rofecoxib	NN	B-NP	O
causes	cause	VBZ	B-VP	O
wheezing	wheezing	NN	B-NP	O
and	and	CC	I-NP	O
NSAIDs	NSAID	NNS	I-NP	O
cause	cause	VBP	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	B-protein
3	3	CD	I-NP	I-protein
great	great	JJ	I-NP	O
grandchildren	grandchild	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
ages	age	NNS	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
and	and	CC	I-NP	O
12	12	CD	I-NP	O
for	for	IN	B-PP	O
whom	whom	WP	B-NP	O
she	she	PRP	B-NP	O
cares	care	VBZ	B-VP	O
for	for	IN	B-PP	O
herself	herself	PRP	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
30-pack-year	30-pack-year	JJ	B-NP	O
and	and	CC	I-NP	O
quit	quit	NN	I-NP	O
in	in	IN	B-PP	O
1968	1968	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
59	59	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/70	160/70	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
Left-sided	Left-sided	JJ	B-NP	O
crackle	crackle	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Trace	Trace	NN	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurovascular	Neurovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
neurologic	neurologic	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	B-protein
of	of	IN	B-PP	O
40	40	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
2.7	2.7	CD	B-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
95	95	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
PACs	PAC	NNS	B-NP	B-cell_type
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate/opacity	infiltrate/opacity	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
to	to	TO	B-PP	O
10.8	10.8	CD	B-NP	O
on	on	IN	B-PP	O
7/26/2005	7/26/2005	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
cardiology	cardiology	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
arrange	arrange	VB	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
from	from	IN	B-PP	O
30	30	CD	B-NP	O
to	to	TO	B-PP	O
23	23	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
hold	hold	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
transfused	transfuse	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
became	become	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
starting	start	VBG	B-VP	O
10/7/2005	10/7/2005	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
6/18/2005	6/18/2005	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
on	on	IN	B-PP	O
5/1/2005	5/1/2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
areas	area	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
OM	OM	NN	I-NP	O
territories	territory	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
on	on	IN	B-PP	O
1/23/2005	1/23/2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
chronically	chronically	RB	B-NP	O
occluded	occlude	VBN	I-NP	O
RCA	RCA	NN	I-NP	B-protein
with	with	IN	B-PP	O
collateral	collateral	JJ	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
tubular	tubular	JJ	I-NP	O
proximal	proximal	JJ	I-NP	O
D1	D1	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
tubular	tubular	JJ	I-NP	O
OM1	OM1	NN	I-NP	O
lesion	lesion	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
stents	stent	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
additional	additional	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
1/21/2005	1/21/2005	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
instance	instance	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
pleuritic	pleuritic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
associated	associate	VBN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
since	since	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
up	up	RP	B-PRT	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Lasix	Lasix	NN	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Diuresis	Diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
gentle	gentle	JJ	I-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
I/O	I/O	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
even	even	RB	B-ADVP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-NP	O
500	500	CD	I-NP	O
cc	cc	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dry	dry	JJ	B-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
her	her	PRP$	B-NP	O
large	large	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
resume	resume	VB	I-VP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
10/9/2005	10/9/2005	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
65-70	65-70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
and	and	CC	I-NP	O
septal	septal	JJ	I-NP	O
walls	wall	NNS	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
AI	AI	NN	I-NP	O
and	and	CC	O	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
area	area	NN	I-NP	O
0.9	0.9	CD	B-NP	O
to	to	TO	I-NP	O
1.0	1.0	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
unilateral	unilateral	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
nicardipine	nicardipine	NN	B-NP	O
,	,	,	O	O
clonidine	clonidine	NN	B-NP	O
patch	patch	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Imdur	Imdur	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
persistently	persistently	RB	B-ADJP	O
hyperkalemic	hyperkalemic	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
between	between	IN	B-PP	O
130-160	130-160	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
close	close	JJ	B-NP	O
followup	followup	NN	I-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
primary	primary	JJ	I-NP	I-protein
care	care	NN	I-NP	I-protein
physician	physician	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
40s	40s	CD	I-NP	O
to	to	TO	B-PP	O
60s	60	NNS	B-NP	O
with	with	IN	B-PP	O
first-degree	first-degree	JJ	B-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
azithromycin/cefotaxime	azithromycin/cefotaxime	NN	B-NP	O
for	for	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
greatly	greatly	RB	B-VP	O
improved	improve	VBD	I-VP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
99-100	99-100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
microalbuminuria	microalbuminuria	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
nonsteroidal	nonsteroidal	JJ	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
through	through	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
angiography	angiography	NN	I-NP	O
on	on	IN	B-PP	O
1/23/2005	1/23/2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
shows	show	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Kayexalate	Kayexalate	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
temporarily	temporarily	RB	B-ADVP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
given	give	VBN	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
K	K	NN	I-NP	I-protein
was	be	VBD	B-VP	O
4.6	4.6	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
colchicine	colchicine	NN	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Mucomyst	Mucomyst	NN	B-NP	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
after	after	IN	B-PP	O
cath	cath	NN	B-NP	O
hydration	hydration	NN	I-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
great	great	JJ	I-NP	I-protein
toe	toe	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
bunion	bunion	NN	I-NP	O
versus	versus	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
gout	gout	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
increased	increase	VBN	B-NP	O
redness	redness	NN	I-NP	O
,	,	,	O	O
warmth	warmth	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
swelling	swell	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
gout	gout	NN	I-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
colchicine	colchicine	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
renally	renally	RB	B-VP	O
dosed	dose	VBN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

NSAIDs	NSAID	NNS	B-NP	O
were	be	VBD	B-VP	O
avoided	avoid	VBN	I-VP	O
given	give	VBN	B-PP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Tylenol	Tylenol	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
showed	show	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
renally	renally	RB	B-NP	O
dose	dose	NN	I-NP	O
prophylactic	prophylactic	JJ	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
on	on	IN	B-PP	O
9/30	9/30	CD	B-NP	O
from	from	IN	B-PP	O
30	30	CD	B-NP	O
to	to	TO	B-PP	O
23	23	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
and	and	CC	O	O
then	then	RB	B-VP	O
maintained	maintain	VBN	I-VP	O
to	to	TO	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
30	30	CD	I-NP	O
since	since	IN	B-PP	O
10/7/2005	10/7/2005	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
post	post	JJ	I-NP	O
cath	cath	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
27.9	27.9	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
repeated	repeat	VBN	B-VP	O
at	at	IN	B-PP	O
28.9	28.9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
groin	groin	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
flank	flank	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

heparin	heparin	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
avoid	avoid	VB	I-VP	O
foods	food	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
in	in	IN	B-PP	O
salt	salt	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
track	track	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
325-650	325-650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
clonidine	clonidine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nicardipine	nicardipine	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
2	2	CD	I-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
180	180	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
60	60	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.d.	q.d.	LS	B-LST	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Alupent	Alupent	NNP	B-NP	O
inhaler	inhal	JJR	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhal	JJR	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Pulmicort	Pulmicort	NNP	B-NP	O
1	1	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-7124025	5-7124025	CD	B-NP	O
PFFocus	PFFocus	NN	I-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Kieth	Kieth	NNP	B-NP	O
Kosiorek	Kosiorek	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
TILLQUETTEGRANT	TILLQUETTEGRANT	NNP	I-NP	O
PACKMISS	PACKMISS	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
Che	Che	NNP	I-NP	O
Olk	Olk	NNP	I-NP	O
Pit	Pit	NNP	I-NP	O
Villea	Villea	NNP	I-NP	O
Lu	Lu	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
REDIGER	REDIGER	NNP	B-NP	O
,	,	,	O	O
COLTON	COLTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BUSTLE	BUSTLE	NNP	B-NP	O
,	,	,	O	O
MARQUIS	MARQUIS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5549175	5549175	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/14/05	5/14/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/14/05	5/14/05	CD	B-NP	O

